From Code to Clinic: How AI Is (and Isn’t) Rewriting the Life of a Drug

AI is transforming drug discovery, but not by replacing the lab. In this episode of William Blair Thinking Presents, Matt Larew, partner and equity research analyst covering life science tools and diagnostics, explains where AI is accelerating early discovery, why wet lab validation still matters, and what real progress looks like as adoption moves from hype to practice.